MSME (Udyam registered) Ministry of MSME
- Category
- Small (2020-21)
- Udyam number
- UDYAM-UK-06-0003852
Apco Pharma Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹12.8 Cr
▲ 14% YoY
Net profit · FY 2024
₹14.94 Lakh
Net margin 1.2%
EBITDA · FY 2024
₹70.21 Lakh
EBITDA margin 5.5%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.33 Cr
Issued & subscribed
Open charges
₹6.91 Cr
Satisfied ₹7.68 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
20
Provident fund records
About Apco Pharma Limited
Data last updated:
Apco Pharma Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 May 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PLC059098. Its GSTIN is 07AAACA9993R2ZO (Delhi). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.33 Cr. It is led by directors including Prakash Setia (Managing Director) and Komal Setia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 359/25 Ignou Road Saiduljab, New Delhi, Delhi, India – 110030.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.8 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹14.94 Lakh (net margin 1.2%) and EBITDA of ₹70.21 Lakh (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 19% over five years.
The company has about 20 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: APCO Pharma. As per MCA filings, the company has open charges of ₹6.91 Cr and satisfied charges of ₹7.68 Cr on record. Court records list 14 cases involving the company, including 2 filed by the company and 12 filed against it; 3 cases are pending.
Apco Pharma Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0003852). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apcopharma.com.
Company details
CIN U74899DL1994PLC059098
Registration Number 059098
Incorporation Date 18 May 1994
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-06-0003852
Recognitions & Rankings of Apco Pharma
Contact details
Apco Pharma Limited's registered office is in New Delhi, Delhi. Its website is apcopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address359/25 Ignou Road Saiduljab, New Delhi, Delhi, India – 110030
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Apco Pharma Limited, buy the company report.
Comprehensive company report
Apco Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Apco Pharma operates one associated brand: APCO Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, contract services, and exports in India. | apcopharma.com |
Business activity
The main business activity of Apco Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Apco Pharma Limited, buy the company report.
Financials of Apco Pharma Limited
FY 2025 filings availableApco Pharma Limited reported revenue of ₹12.8 Cr (up 14% YoY) for FY 2024.
Revenue · FY 2024
₹12.8 Cr ▲ 14%
Net profit · FY 2024
₹14.94 Lakh margin 1.2%
EBITDA · FY 2024
₹70.21 Lakh margin 5.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 22%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 16%
5 years · compounded
▲ 8%
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 14% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹12.8 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹70.21 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.94 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apco Pharma Limited, buy the company report.
Board of directors of Apco Pharma Limited
Apco Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Komal Setia | Director | 30 Sep 2004 | 22 Years 0 Months | Current |
| Rishab Setia | Director | 01 Apr 2020 | 6 Years 6 Months | Current |
| Prakash Setia | Managing Director | 01 Apr 2002 | 24 Years 6 Months | Current |
Peer comparison
Apco Pharma Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Galen Pharmaceuticals Limited | ₹12.87 Cr (FY 2025) | -15.0% | Vadodara, Gujarat, India | |||
| C and C Organics Private Limited | ₹12.84 Cr (FY 2025) | 31.0% | Delhi, India | |||
| Recurso Wellness Private Limited | ₹12.82 Cr (FY 2023) | 159.0% | Ahmedabad, Gujarat, India | |||
| Apco Pharma Limitedthis company | ₹12.8 Cr (FY 2024) | ₹14.94 Lakh | 1.2% | 14.0% | 20 | New Delhi, Delhi, India |
| Salubrity Biotech Limited | ₹12.8 Cr (FY 2025) | 2.0% | Kolkata, West Bengal, India | |||
| Habitare Pharma Private Limited | ₹12.79 Cr (FY 2025) | 17.0% | Barwala, Haryana, India | |||
| Thaiger Pharma Private Limited | ₹12.77 Cr (FY 2025) | -15.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Apco Pharma Limited, buy the company report.
Auditor
Apco Pharma Limited is audited by M/S ANIL JAIN & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M/S ANIL JAIN & CO. | FY 2024 | 000189C |
Shareholding
The shareholding of Apco Pharma Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Apco Pharma Limited, buy the company report.
Charges & borrowings
Open charges
₹6.91 Cr
Satisfied charges
₹7.68 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Sep 2024 | 101005241 | Others | ₹5.03 Cr | Open | |
| 18 Aug 2021 | 100477827 | Tata Capital Financial Services Limited | ₹13.3 Lakh | Open | |
| 13 Nov 2010 | 10298102 | Bank of Baroda | ₹1.75 Cr | Open | |
| 13 Oct 2022 | 100626353 | Yes Bank Limited | ₹3.58 Cr | Satisfied | |
| 19 Dec 2009 | 10191996 | The Bank of Rajasthan Limited | ₹1.25 Cr | Satisfied |
To see the full charge records of Apco Pharma Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Apco Pharma Limited has 14 court cases on record: 2 filed by Apco Pharma, 12 filed against it. 3 cases are pending and 11 are disposed.
Total cases
14
Filed by the company
2
Filed against the company
12
Pending
3
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 10 | 3 |
| High courts | 3 | 2 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Muzaffarpur, Bihar | Court case (Cr. Case Complaint (O)) | Filed against the company by State of Bihar Through Anil Kumar Sah | Pending |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed against the company by Ms.Scorpion Cantainer (P) Ltd, | Pending |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed against the company by an individual | Pending |
| District court, Bharatpur, Rajasthan | Criminal case | Filed against the company by State of Rajasthan | Disposed |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
To see the full case history of Apco Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apco Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Apco Pharma Limited has a workforce of 20 employees on its EPFO records as of Aug 31, 2024, across 1 active EPFO establishment.
Employee count
20
Active EPFO establishments
1
Employee growth
-13.04%
GST
Apco Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACA9993R2ZO | Delhi | Active | 04 Dec 2024 |
| 05AAACA9993R1ZT | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Apco Pharma Limited, buy the company report.
Recent activity
Apco Pharma Limited has 5 board changes on record since 2002: 3 appointments and 2 cessations. The latest: Rishab Setia ceased to be Additional Director on 31 Dec 2020.
AGM
Apco Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Apco Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge registered on 13 Oct 2022 via Charge ID 100626353 with Yes Bank Limited was fully satisfied on 25 Nov 2024.
Charges
A charge with Others amounted to Rs. 5.03 Cr with Charge ID 101005241 was registered on 26 Sep 2024.
Charges
A charge with Yes Bank Limited of Rs. 3.58 Cr registered on 13 Oct 2022 with Charge ID 100626353 was modified on 12 Dec 2023.
Charges
A charge with Yes Bank Limited amounted to Rs. 3.58 Cr with Charge ID 100626353 was registered on 13 Oct 2022.
Charges
A charge with Tata Capital Financial Services Limited amounted to Rs. 0.13 Cr with Charge ID 100477827 was registered on 18 Aug 2021.
Ceased
Rishab Setia ceased to be Additional Director.
Ceased
Ashok Kumar Setia ceased to be Director.
Appointed
Rishab Setia was appointed as Director.
Charges
A charge registered on 19 Dec 2009 via Charge ID 10191996 with The Bank Of Rajasthan Limited was fully satisfied on 21 Mar 2011.
Charges
A charge registered on 26 Sep 2008 via Charge ID 10126515 with The Bank Of Rajasthan Limited was fully satisfied on 21 Mar 2011.
10 earlier events are in the company report.
Frequently asked questions
Apco Pharma is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 May 1994 (32+ years old) and is registered under CIN U74899DL1994PLC059098.
Apco Pharma has 3 current directors:
- Prakash Setia - Managing Director
- Komal Setia - Director
- Rishab Setia - Director
The latest financial statements of Apco Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Apco Pharma is 07AAACA9993R2ZO, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 05AAACA9993R1ZT (Uttarakhand).
The CIN (Corporate Identification Number) of Apco Pharma is U74899DL1994PLC059098. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apco Pharma has 14 court cases on record: 2 filed by the company and 12 filed against it. 3 are pending. Most are in the district courts.
Apco Pharma was incorporated on 18 May 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Apco Pharma by revenue are Galen Pharmaceuticals Limited, C and C Organics Private Limited, Recurso Wellness Private Limited, Salubrity Biotech Limited, Habitare Pharma Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rishab Setia ceased to be Additional Director on 31 Dec 2020. Ashok Kumar Setia ceased to be Director on 14 Oct 2020. Rishab Setia was appointed as Director on 01 Apr 2020. Apco Pharma has 5 board changes on record in total.
Yes, Apco Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0003852).
Apco Pharma can be reached through the website apcopharma.com. Its registered office is in New Delhi, Delhi, India.